Cancer

17 results.

September 21, 2026 What is vitamin C and why are cancer researchers interested in it?

Highlights Vitamin C is an essential nutrient that we obtain by eating foods like citrus fruits and leafy greens. It supports several important systems and…

September 21, 2026 Phase 2 trial suggests vitamin C may benefit people with pre-cancer blood disorders

Highlights People with pre-cancer blood disorders and early-stage blood cancers who took daily doses of 1,000 mg oral vitamin C were significantly more likely to…

May 4, 2026 How Dr. Peter A. Jones transformed VAI into a research powerhouse

Dr. Peter Jones arrived in Grand Rapids with a vision: build Van Andel Institute into one of the world’s premier research organizations.

More…

May 19, 2025 Using viral mimicry to help the immune system see — and fight — cancer

Cancer cells are masters of disguise.

Like villains in bad movies, they evade detection by masquerading as healthy cells, turning off the body’s built-in alarm…

December 9, 2024 Van Andel Institute, Johns Hopkins University scientists to receive prestigious Harvey Prize

GRAND RAPIDS, Mich. (Dec. 9, 2024) — A trio of esteemed scientists from Van Andel Institute and Johns Hopkins University will receive the Harvey Prize for their…

October 21, 2024 Van Andel Institute Chief Scientific Officer Dr. Peter A. Jones elected to National Academy of Medicine

GRAND RAPIDS, Mich. (Oct. 21, 2024) — Van Andel Institute Chief Scientific Officer Peter A. Jones, Ph.D., D.Sc. (hon), has been elected to the

August 3, 2023 Making an impact in the real-world: Five things to know about the Van Andel Institute–Stand Up To Cancer Epigenetics Dream Team

Since October 2014, the Van Andel Institute–Stand Up To Cancer Epigenetics Dream Team has supported and launched breakthrough clinical trials that explore potential new…

November 1, 2022 Combining two cancer medications may increase survival in relapsed myelodysplastic syndrome, lays groundwork for future cancer therapies

GRAND RAPIDS, Mich. (Nov. 1, 2022) — A pair of cancer medications that act as a one-two punch against malignant cells demonstrated increased survival in…